These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8694550

  • 21. Carcinoembryonic antigen level is related to tumor invasion into the serosa of the stomach: study on 166 cases and suggestion for new therapy.
    Zhang YH, Li Y, Chen C, Peng CW.
    Hepatogastroenterology; 2009; 56(96):1750-4. PubMed ID: 20214231
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.
    Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Carone MD, Aloe S, Tedesco M, Mancini R, Casale V, Carlini S, Casciani CU, Roselli M, Guadagni F.
    Anticancer Res; 1999; 19(2B):1363-8. PubMed ID: 10365107
    [Abstract] [Full Text] [Related]

  • 24. [The role of tumor markers in diagnosing metastases of gastric cancer: preoperative diagnostics (part I)].
    Kurygin AA, Maĭstrenko NA, Khrykov GN, Beliak NP.
    Vestn Khir Im I I Grek; 2009; 168(4):16-9. PubMed ID: 19947409
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
    Vallejo J, Torres-Avisbal M, Contreras P, Rodríguez-Liñán M, Rebollo A, González F, Benítez A, Infante J, Mateo A.
    Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C.
    Anticancer Res; 2002 Aug; 22(4):2311-6. PubMed ID: 12174919
    [Abstract] [Full Text] [Related]

  • 31. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER].
    Buda F, Aragona P, Giani G, Sisto R, Di Nardo G, Binotto F, Gangemi P, De Zerbi T, Gentile G, Papadia A.
    G Ital Oncol; 1989 Aug; 9(2-3):67-72. PubMed ID: 2767730
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phospholipids, tumour marker and beta-CrossLaps in diagnosis of gastric carcinoma.
    Oremek GM, Sapoutzis N, Lorenz M.
    Anticancer Res; 2003 Aug; 23(2A):859-63. PubMed ID: 12820314
    [Abstract] [Full Text] [Related]

  • 34. Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancer.
    Lindmark G, Kressner U, Bergström R, Glimelius B.
    Anticancer Res; 1996 Aug; 16(2):895-8. PubMed ID: 8687147
    [Abstract] [Full Text] [Related]

  • 35. [Preoperative serum levels of CEA and CA19-9 in patients with gastric cancer].
    Roviello F, Garosi L, Marrelli D, De Stefano A, Udhris C, Messano A, Pinto E.
    Minerva Chir; 1996 Mar; 51(3):133-9. PubMed ID: 8684652
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer.
    Ishigami S, Sakamoto A, Uenosono Y, Nakajo A, Okumura H, Matsumoto M, Setoyama T, Arigami T, Uchikado Y, Arima H, Natsugoe S, Aikou T.
    J Surg Res; 2008 Aug; 148(2):205-9. PubMed ID: 17936797
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Abbolito MR, Mariotti S, Aloe S, Carone MD, Graziano F, Tedesco M, Martini F, Mancini R, Stigliano V, Roselli M, Guadagni F.
    Anticancer Res; 2001 Aug; 21(2B):1263-70. PubMed ID: 11396197
    [Abstract] [Full Text] [Related]

  • 40. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K, Yamamoto T, Yoshioka K, Iida M, Miyagawa H, Yoshikawa T, Sugino S, Kondo M.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.